BIOTRICITY INC. ·
BTCY 8-K 2026-09-28
BIOTRICITY INC. (BTCY) 8-K dated 2026-09-28 — accession 0001493152-26-044407.
BIOTRICITY INC. (BTCY) is a medical devices company listed on NASDAQ.
BIOTRICITY INC. filed a 8-K on 2026-09-28. Accession 0001493152-26-044407.
This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported BTCY revenue for 2026-03-31 was $16.0M. Net income was -$2.4M. Revenue was up 16.0% from 2025-03-31 to 2026-03-31. BTCY currently screens at market cap $3.5M.
Not investment advice. The BTCY SEC hub lists recent forms. The stock page is the research view.